Why does treating a venomous snake bite cost as much as a house? Zachary Crockett slithers over to North Carolina to find out.

SOURCES:
- Steve Anderson, emergency medicine business unit leader at BTG Pharmaceuticals.
- Nick Brandehoff, professor of emergency medicine at the University of Colorado and executive director of the Asclepius Snakebite Foundation.
- Sean Bush, emergency physician and president of the North American Society of Toxinology.
- Nitin Deshpande, business consultant with Premium Serums & Vaccines.
- Jack Facente, owner-operator of AGRITOXINS Venom Production Laboratory.

RESOURCES:
- "This New Antivenom Defangs the Toxins of Cobras, Black Mambas and More," by Cassandra Willyard (Scientific American, 2024).
- "Perspectives on Snakebite Envenoming Care Needs Across Different Sociocultural Contexts and Health Systems: A Comparative Qualitative Analysis Among U.S. and Brazilian Health Providers," by Eleanor Strand, Felipe Murta, Anna Tupetz, Charles J. Gerardo, et al. (Toxicon: X, 2023).
- "Access to Antivenoms in the Developing World: A Multidisciplinary Analysis," by Julien Potet, David Beran, David J. Williams, et al. (Toxicon: X, 2021).
- "The Lab Saving the World From Snake Bites," by Myles Karp (Smithsonian Magazine, 2020).
- "Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment," by Carmen Heredia Rodriguez (NPR, 2019).
- "Summer Bummer: A Young Camper’s $142,938 Snakebite," by Carmen Heredia Rodriguez (KFF Health News, 2019).
- "The Amazing Science Behind Fatal Snake Bites," (BBC News, 2015).
- "Southern Californians See a Rise in Venomous Snakes," by Rebecca Fairley Raney (The New York Times, 2006).
- Venom Week.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Buying or selling a home? How the Fundamentals of Supply and Demand Affect Housing Prices